Real-World Study of Ceftazidime Avibactam in China
About the study
This observational study will enroll approximately 450 in patients. Patients treated with CAZ AVI for at least 1 dose at around 20 research centers in China will be enroll.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion criteria：
- Initiate ≥1 dose of ceftazidime-avibactam during hospitalization.
- Aged ≥ 18 years old at the time of the informed consent signature.
EXCLUSION CRITERIA
Provide signed informed consent. Exclusion criteria：
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Hospital Acquired Pneumonia,Ventilator Acquired Pneumonia,Complicated Intra Abdominal Infections
Age (in years)
18+
Participants needed
450
Est. Completion Date
Mar 31, 2024
Treatment type
Observational
Sponsor
Pfizer
ClinicalTrials.gov identifier
NCT05487586
Study number
C3591037
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?